1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Vasomera (PB1046): new trials by email Literature Review of Vasomera (PB1046) trials Research Report on Vasomera (PB1046)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension Vasomera (PB1046), 0.9% Sodium Chloride - Essential Hypertension | Phase 1 | Completed | PhaseBio Pharmaceuticals Inc. | 68 | 2012-01-01 | 2013-01-04 |
Essential Hypertension (1) · Hypertension (1)
PhaseBio Pharmaceuticals Inc. (1)
United States (1)
Mark Matson, MD (1)